PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.78%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
11.98%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
24.51%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
24.51%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
21.84%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
14.00%
Positive EPS growth while TSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
18.75%
Positive diluted EPS growth while TSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.23%
Share count expansion well above TSM's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.00%
Diluted share reduction more than 1.5x TSM's 0.02%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-51.00%
Negative OCF growth while TSM is at 10.34%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-62.58%
Negative FCF growth while TSM is at 22.91%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
517.81%
10Y revenue/share CAGR above 1.5x TSM's 170.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
65.46%
5Y revenue/share CAGR above 1.5x TSM's 38.48%. David Dodd would look for consistent product or market expansions fueling outperformance.
14.54%
3Y revenue/share CAGR at 50-75% of TSM's 23.15%. Martin Whitman would question if the firm lags behind competitor innovations.
954.88%
OCF/share CAGR of 954.88% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-33.39%
Negative 5Y OCF/share CAGR while TSM is at 33.21%. Joel Greenblatt would question the firm’s operational model or cost structure.
-69.21%
Negative 3Y OCF/share CAGR while TSM stands at 24.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
624.87%
Net income/share CAGR above 1.5x TSM's 155.41% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
160.46%
5Y net income/share CAGR above 1.5x TSM's 25.60%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-17.86%
Negative 3Y CAGR while TSM is 24.34%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1627.00%
10Y equity/share CAGR above 1.5x TSM's 123.93%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
115.78%
5Y equity/share CAGR above 1.5x TSM's 34.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.06%
3Y equity/share CAGR 1.25-1.5x TSM's 27.36%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.75%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
19.10%
Inventory growth well above TSM's 6.54%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.53%
Asset growth well under 50% of TSM's 7.70%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
8.62%
1.25-1.5x TSM's 6.98%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-1.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
9.25%
R&D growth drastically higher vs. TSM's 0.46%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.56%
SG&A growth well above TSM's 4.13%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.